BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17628142)

  • 1. Two-component signaling in the virulence of Staphylococcus aureus: a silkworm larvae-pathogenic agent infection model of virulence.
    Kurokawa K; Kaito C; Sekimizu K
    Methods Enzymol; 2007; 422():233-44. PubMed ID: 17628142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silkworm larvae as an animal model of bacterial infection pathogenic to humans.
    Kaito C; Akimitsu N; Watanabe H; Sekimizu K
    Microb Pathog; 2002 Apr; 32(4):183-90. PubMed ID: 12079408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silkworm pathogenic bacteria infection model for identification of novel virulence genes.
    Kaito C; Kurokawa K; Matsumoto Y; Terao Y; Kawabata S; Hamada S; Sekimizu K
    Mol Microbiol; 2005 May; 56(4):934-44. PubMed ID: 15853881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Staphylococcus aureus virulence factors using a silkworm model.
    Miyazaki S; Matsumoto Y; Sekimizu K; Kaito C
    FEMS Microbiol Lett; 2012 Jan; 326(2):116-24. PubMed ID: 22092964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of silkworm larvae to study pathogenic bacterial toxins.
    Hossain MS; Hamamoto H; Matsumoto Y; Razanajatovo IM; Larranaga J; Kaito C; Kasuga H; Sekimizu K
    J Biochem; 2006 Sep; 140(3):439-44. PubMed ID: 16891331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model.
    Takemura-Uchiyama I; Uchiyama J; Kato S; Inoue T; Ujihara T; Ohara N; Daibata M; Matsuzaki S
    FEMS Microbiol Lett; 2013 Oct; 347(1):52-60. PubMed ID: 23869440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invertebrates as animal models for Staphylococcus aureus pathogenesis: a window into host-pathogen interaction.
    García-Lara J; Needham AJ; Foster SJ
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):311-23. PubMed ID: 15708304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic view of cell physiology and virulence of Staphylococcus aureus.
    Hecker M; Becher D; Fuchs S; Engelmann S
    Int J Med Microbiol; 2010 Feb; 300(2-3):76-87. PubMed ID: 20005169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low virulence Staphylococcus aureus strains in a rabbit skin infection model.
    Meulemans L; Hermans K; Duchateau L; Haesebrouck F
    Vet Microbiol; 2007 Dec; 125(3-4):333-40. PubMed ID: 17644278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones.
    Barman TK; Arora P; Rao M; Bhadauriya T; Upadhyay DJ
    J Infect Chemother; 2008 Apr; 14(2):166-9. PubMed ID: 18622683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding of bacterial virulence using the silkworm infection model.
    Kaito C
    Drug Discov Ther; 2016 Feb; 10(1):30-3. PubMed ID: 26971552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission?
    Massey RC; Horsburgh MJ; Lina G; Höök M; Recker M
    Nat Rev Microbiol; 2006 Dec; 4(12):953-8. PubMed ID: 17109032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Silkworm Larva Model in Phage Therapy Experiments.
    Uchiyama J; Takemura-Uchiyama I; Matsuzaki S
    Methods Mol Biol; 2019; 1898():173-181. PubMed ID: 30570732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence.
    van Belkum A
    Curr Opin Infect Dis; 2006 Aug; 19(4):339-44. PubMed ID: 16804380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of multi-site infection model in zebrafish larvae for studying Staphylococcus aureus infectious disease.
    Li YJ; Hu B
    J Genet Genomics; 2012 Sep; 39(9):521-34. PubMed ID: 23021551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The yjeQ gene is required for virulence of Staphylococcus aureus.
    Campbell TL; Henderson J; Heinrichs DE; Brown ED
    Infect Immun; 2006 Aug; 74(8):4918-21. PubMed ID: 16861682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis.
    Majcherczyk PA; Barblan JL; Moreillon P; Entenza JM
    Microb Pathog; 2008; 45(5-6):408-14. PubMed ID: 18930804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Staphylococcus aureus and the human immune system].
    Slobodníková L
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):130-8. PubMed ID: 7489137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-Scale Screening and Identification of Novel Pathogenic Staphylococcus aureus Genes Using a Silkworm Infection Model.
    Paudel A; Hamamoto H; Panthee S; Matsumoto Y; Sekimizu K
    J Infect Dis; 2020 May; 221(11):1795-1804. PubMed ID: 31912866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo experimental model for the study of the influence of subinhibitory concentrations of phenyllactic acid on Staphylococcus aureus pathogenicity.
    Chifiriuc MC; Bleotu C; Ditu LM; Smarandache D; Săsărman E; Banu O; Drăcea O; Larion C; Veronica L
    Roum Arch Microbiol Immunol; 2009; 68(1):34-7. PubMed ID: 19507625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.